Office Policies
Patient information: Asthma treatment in adolescents and adults (Beyond the Basics)
AuthorChristopher H Fanta, MD |
Section EditorBruce S Bochner, MD |
Deputy EditorHelen Hollingsworth, MD |
Contents of this article
-
ASTHMA TREATMENT OVERVIEW -
CONTROLLING ASTHMA TRIGGERS -
MONITORING SYMPTOMS AND LUNG FUNCTION -
CATEGORIES OF ASTHMA SYMPTOMS -
ASTHMA RELIEVER MEDICATIONS -
ASTHMA CONTROLLER MEDICATIONS -
EXERCISE-INDUCED ASTHMA -
ASTHMA IN PREGNANCY -
ASTHMA ATTACK TREATMENT -
WHERE TO GET MORE INFORMATION -
ACKNOWLEDGMENT -
REFERENCES
GRAPHICS
ASTHMA TREATMENT OVERVIEW
Asthma is a common lung disease affecting millions of people worldwide. It is caused by narrowing of the airways (breathing tubes) in the lungs. This narrowing is partially or completely reversible. Symptoms of asthma include wheezing, coughing, chest tightness, and shortness of breath. These symptoms tend to come and go, and are related to the degree of airway narrowing in the lungs. The airways are sensitive to a variety of stimuli, which may include viral illnesses (eg, the common cold), allergens, exercise, medicines, or environmental conditions.
Asthma can usually be treated successfully. This requires being well informed about the disease and being an active player in managing it.
This topic will review asthma treatment in adolescents and adults (adolescents defined as children 12 years and older). Other topics about asthma are also available. (See "Patient information: How to use a peak flow meter (Beyond the Basics)" and "Patient information: Asthma inhaler techniques in adults (Beyond the Basics)" and "Patient information: Asthma and pregnancy (Beyond the Basics)" and "Patient information: Exercise-induced asthma (Beyond the Basics)".)
Topics about asthma in children are also available. (See "Patient information: Asthma symptoms and diagnosis in children (Beyond the Basics)" and "Patient information: Asthma treatment in children (Beyond the Basics)" and "Patient information: Asthma inhaler techniques in children (Beyond the Basics)" and "Patient information: Trigger avoidance in asthma (Beyond the Basics)".)
CONTROLLING ASTHMA TRIGGERS
The factors that set off and worsen asthma symptoms are called "triggers." Identifying and avoiding asthma triggers are essential steps in preventing asthma flare-ups. Common asthma triggers generally fall into several categories:
-
Allergens (including dust, pollen, and furred animals) -
Respiratory infections -
Irritants (such as tobacco smoke or chemicals) -
Physical activity -
Certain medicines, known as beta blockers -
Emotional stress -
Menstrual cycle in some women
A small number of patients will develop asthmatic symptoms after exposure to aspirin or other nonsteroidal antiinflammatory medications, like ibuprofen or naproxen. (See "Patient information: Trigger avoidance in asthma (Beyond the Basics)" and "Allergen avoidance in the treatment of asthma and allergic rhinitis".)
After identifying potential asthma triggers, you and your clinician should develop a plan to deal with the triggers. There are three main options:
-
Avoid the trigger entirely (eg, if allergic to animals, do not own pets, if sensitive to aspirin or related medications, avoid all forms of these medications). -
Limit exposure to the asthma trigger if it cannot be completely avoided (eg, move to another seat if someone with strong perfume is seated nearby, have someone else do house cleaning if allergic to dust mites). -
Take an extra dose of bronchodilator medication before exposure to an asthma trigger. Talk with a healthcare provider before using this approach; it should only be used if the first two options are not possible. Be careful not to use more than twice the amount of medication normally used.
Special approaches to unavoidable allergic triggers include allergy desensitization injections (“allergy shots”) and an injected medication targeting allergy proteins in the blood (anti-immunoglobulin E antibody, called omalizumab).
MONITORING SYMPTOMS AND LUNG FUNCTION
Successful asthma treatment relies on your ability to monitor your condition over time. This is done by recording the frequency and severity of symptoms (such as wheezing, coughing, and shortness of breath) and by measuring lung function with a peak flow meter
Asthma diary — A healthcare provider may recommend keeping a daily asthma diary when symptoms are not well controlled or when starting a new treatment. In the diary, your peak flow readings, asthma symptoms (eg, coughing, wheezing), and medications are recorded (figure 1).
A periodic diary may be recommended if you have stable symptoms and your medications have not changed recently. This type of diary can be completed before visiting the healthcare provider and helps you and your healthcare provider to determine whether the asthma treatment plan needs to be adjusted (form 1).
Peak expiratory flow (PEF) — PEF measures the rate at which you can exhale. This rate is dependent on the degree of airway narrowing. PEF monitoring can be used to monitor your lung function and response to treatment, assess the severity of asthma attacks, and guide decisions regarding treatment.
Peak flow meters are inexpensive and easy to use. Adults with persistent asthma may, at times, use a peak flow meter once or twice daily to monitor their lung function. (See "Patient information: How to use a peak flow meter (Beyond the Basics)".)
Review of treatment — Adolescents and adults with asthma are usually seen by their healthcare provider once or twice a year if their asthma is well-controlled or more often if their asthma is not well-controlled. At these visits, the healthcare provider will evaluate the severity and frequency of your asthma symptoms and response to treatment. If your asthma control has been adequate for at least three months, your medication dose may be decreased. If control is not adequate, your medication schedule, delivery technique, and trigger avoidance will be reviewed, and your medication dose may be increased.
CATEGORIES OF ASTHMA SYMPTOMS
The medications used for asthma treatment vary according to your age, the severity of asthma, and the level of symptom control. The asthma treatment plan must be reviewed and adjusted on a regular basis. If symptoms are well controlled, medication can often be reduced. As symptoms worsen, medication should be increased.
Intermittent asthma — People with intermittent asthma are defined as those who have the following characteristics (see "Treatment of intermittent and mild persistent asthma in adolescents and adults"):
-
Symptoms of asthma occur two or fewer days per week -
Asthma does not interfere with daily activities -
Nighttime symptoms awaken you two or fewer nights per month -
Oral steroid treatment (eg, prednisone) is needed no more than once per year to treat increased asthma symptoms
If your asthma is triggered only by vigorous exercise (exercise-induced bronchoconstriction), you might fit into this category, even if you have episodes of asthma with exercise more than twice per week. (See "Patient information: Exercise-induced asthma (Beyond the Basics)".)
Persistent asthma — People with persistent asthma have symptoms regularly. There may be days when your activities are limited due to symptoms, and you may be awakened from sleep.
Based on how frequently you have symptoms and the severity of your asthma flares, the clinician will determine whether your persistent asthma is mild, moderate, or severe. Treatment plans will vary based upon the severity of your asthma, as well as your level of symptom control. (See "Treatment of moderate persistent asthma in adolescents and adults".)
The symptoms that are used to determine your asthma severity include the number of days per week that you have one or more of the following:
-
Symptoms such as cough, wheeze, and shortness of breath -
Nighttime symptoms that awaken you from sleep -
Symptoms that need treatment with a bronchodilator (reliever medication) -
Symptoms that affect your ability to participate in normal activities
ASTHMA RELIEVER MEDICATIONS
Bronchodilators — Short-acting bronchodilators (usually beta-2 agonists) relieve asthma symptoms rapidly, by temporarily relaxing the muscles around narrowed airways. In the United States, albuterol (Ventolin®, Proventil®, and ProAir® plus generic albuterol) is the most commonly used short-acting bronchodilator. These medications are sometimes referred to as "quick-acting relievers." People with intermittent asthma, the mildest form of asthma, will require these symptom-relieving medications only occasionally.
The preferred way of taking medication for mild intermittent asthma is by inhalation with a metered dose inhaler. This method allows the medication to take effect rapidly with maximum strength and minimal side effects. (See "Patient information: Asthma inhaler techniques in adults (Beyond the Basics)".)
There is no benefit to using short-acting bronchodilators on a regular basis. If your asthma symptoms are consistently occurring more than two days per week, you should review your treatment plan with a healthcare provider. Other medications are more effective for persistent symptoms in this situation.
Side effects of bronchodilators — Some people feel shaky, have a rapid heart rate, and/or feel anxious after using an inhaled short-acting bronchodilator. Using a single puff rather than the usual two puffs may limit these side effects and only minimally decrease their benefit. In addition, these side effects usually become less noticeable over time.
ASTHMA CONTROLLER MEDICATIONS
People with persistent asthma need to take medication on a daily basis to keep their asthma under control, even if there are no symptoms of active asthma on a given day. Medications taken daily for asthma are called "long-term controller" medicines.
Some controller medicines are delivered by inhaler, while others are taken as a tablet. The doses and types of controller medications prescribed depend upon your asthma severity and level of symptom control.
Inhaled steroids — Inhaled steroids (also known as glucocorticoids) act to decrease inflammation (swelling) of the airways over time. The steroids used to treat asthma are different from the ones athletes take to build muscle. Regular treatment with an inhaled steroid reduces the frequency of symptoms (and the need for inhaled bronchodilators for symptom relief), improves quality of life, and decreases the risk of serious attacks.
A number of inhaled steroid medications are available, most of which are taken once or twice a day. An inhaled bronchodilator is still used as needed for relief of symptoms and before exposure to asthma triggers. There is no need to take the inhaled bronchodilator before each daily dose of inhaled steroid.
Side effects of inhaled steroids — Unlike steroids that are taken as tablet or liquid by mouth, very little of the inhaled steroid is absorbed into the bloodstream, and there are few side effects. However, as the dose of inhaled steroid is increased, more of the medication is absorbed into the bloodstream, and the risk of side effects increases.
The most common side effect of low-dose inhaled steroid is oral candidiasis (thrush). This can usually be prevented by taking inhaled steroids from a metered dose inhaler with a spacer (which helps to deliver medication to the lungs, rather than the mouth) (picture 1). You should rinse your mouth or brush your teeth and tongue immediately after inhalation. A hoarse voice and sore throat (without thrush) are less common side effects that are usually managed by changing to a different inhaled steroid preparation.
Rare but possible side effects of long-term high-dose inhaled steroid treatments, besides oral candidiasis, include cataracts, increased pressure in the eye (glaucoma), easy bruising of the skin, and increased bone loss (osteoporosis).
The risk of these complications is far less with inhaled glucocorticoids compared with oral glucocorticoids (eg, prednisone). Nevertheless, every effort should be made to use the lowest possible dose that controls asthma and minimizes the risk of an asthma attack.
Long-acting bronchodilators — A long-acting inhaled bronchodilator is often recommended, in combination with an inhaled steroid, for adults with persistent asthma. Long-acting bronchodilators (salmeterol, formoterol) are recommended because they work for a longer period than short-acting bronchodilators (for 12 or more hours). A device that contains both an inhaled steroid and a long-acting bronchodilator is usually preferred (Advair®, Symbicort®, Seretide® in Europe, and Dulera®). A short-acting bronchodilator is still used as needed for immediate relief of asthma symptoms.
Cromolyn and nedocromil — Cromolyn (Intal®) and nedocromil may be recommended as an alternative to low-dose inhaled glucocorticoids; however, only the cromolyn nebulizer solution is available in the United States. These medicines work by decreasing the activity of allergy cells. They are generally less effective than inhaled glucocorticoids. They are also less convenient because they must be used three or four times daily.
Cromolyn can be used to prevent symptoms before exposure to an asthma trigger or before exercising. (See "Patient information: Exercise-induced asthma (Beyond the Basics)".)
Leukotriene modifiers — Leukotriene modifiers, such as montelukast (Singulair®), zafirlukast (Accolate®), or zileuton (Zyflo®) are an alternative to inhaled glucocorticoids. Leukotriene modifiers work by opening narrowed airways, decreasing inflammation, and decreasing mucus production. They are taken by mouth as a pill once or twice daily and have very few side effects. Mood alteration and depression are rare side effects. However, compared with inhaled glucocorticoids, leukotriene modifiers are generally somewhat less effective in controlling asthma.
Leukotriene modifiers can be used to prevent symptoms before exposure to a trigger or before exercising. (See "Patient information: Exercise-induced asthma (Beyond the Basics)".)
Oral steroids — If symptoms are not controlled with the above medications, an oral steroid (eg, prednisone) may be added to the treatment regimen. Steroids used to treat asthma are in a class called glucocorticoids and are different from the ones athletes take to build muscle. Most healthcare providers recommend a 5 to 10 day course of oral glucocorticoids for flares of asthma.
EXERCISE-INDUCED ASTHMA
If exercise is a trigger for asthma, an extra dose of bronchodilator medication, leukotriene modifier, or cromolyn taken before exercise can be used to prevent asthma symptoms. A topic review that discusses exercise-induced asthma is available separately. (See "Patient information: Exercise-induced asthma (Beyond the Basics)".)
ASTHMA IN PREGNANCY
Asthma is the most common chronic medical condition that affects the lungs during pregnancy. About 4 percent of pregnant women have asthma. With good asthma treatment during pregnancy, most women can breathe easily, have a normal pregnancy, and give birth to a healthy baby. It is essential to keep asthma well controlled during pregnancy to ensure that optimal levels of oxygen reach the baby.
Before becoming pregnant, women with asthma should learn as much as they can about the condition and talk with their healthcare providers about asthma treatment during pregnancy. More information about asthma during pregnancy is presented separately. (See "Patient information: Asthma and pregnancy (Beyond the Basics)".)
ASTHMA ATTACK TREATMENT
The term "asthma attack" is somewhat confusing because it does not distinguish between a mild increase in symptoms and a life-threatening episode. Symptoms may be aggravated by changes in air quality, the common cold, exercise, exposure to allergens, or changes in the weather. These triggers can cause mild, moderate, or severe symptoms to develop. Any of these changes could be considered an asthma "attack."
Some people have periodic, mild asthma attacks that never require emergency care, while others have severe and sudden asthma attacks that require a call for emergency medical services.
Asthma action plan — You should work with your healthcare provider to develop personalized directions (also called an asthma action plan) to follow when symptoms increase or your peak flow begins to decrease. Asthma action plans for adolescents and adults and school asthma action plans are available (form 2 and form 3A-C).
Peak expiratory flow rates can be divided into three zones, which are assigned colors similar to those of a traffic light. These zones can be used to make decisions about the need for treatment:
Green — Green signals that the lungs are functioning well. When symptoms are not present or are well controlled, you should continue your regular medicines and activities.
Yellow — Yellow is a sign that the airways in the lungs are somewhat narrowed, making it difficult to move air in and out; asthma symptoms may be more frequent or more severe. A short-term change or increase in medication is generally required. You should change or increase your medication according to the plan that was discussed with your provider.
Red — Red is a sign that the airways are severely narrowed and require immediate treatment. Symptoms are usually more severe and frequent. In addition to using 2 to 4 puffs of the quick-acting reliever inhaler (eg, albuterol), steroid tablets are often required to bring relief, according to the plan discussed with your provider.
Emergency care plan — You should work with your healthcare provider to formulate an emergency care plan that explains exactly what to do if symptoms worsen. This may include more frequent use of a reliever medication (eg, albuterol) and starting or increasing the dose of a long-term controller medication (eg, prednisone).
However, if symptoms are severe and worsen or do not improve after use of a quick-acting reliever medication, someone should immediately call for emergency medical assistance. Severe asthma attacks can be fatal if not treated promptly. In most areas of the United States, emergency medical assistance is available by calling 911. You should not attempt to drive yourself to the hospital, and you should not ask someone else to drive. Calling 911 is safer than driving for two reasons:
-
From the moment EMS personnel arrive, they can begin evaluating and treating your asthma. When driving in a car, treatment cannot begin until you arrive in the emergency department. -
If a dangerous complication of asthma occurs on the way to the hospital, EMS personnel may be able to treat the problem immediately.
Following an asthma attack, most people are given a 5 to 10 day course of an oral steroid medication (eg, prednisone). This treatment helps to reduce the risk of a second asthma attack.
Wear medical identification — Many people with medical conditions wear a bracelet, necklace, or similar alert tag at all times. If an accident occurs and you cannot explain your condition, the identification will help responders provide appropriate care.
The alert tag should include a list of major medical conditions and allergies, as well as the name and phone number of an emergency contact. One device, Medic Alert® (www.medicalert.com), provides a toll-free number that emergency medical workers can call to find out a person's medical history, list of medications, family emergency contact numbers, and healthcare provider names and numbers.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient information: Asthma in adults (The Basics)
Patient information: Avoiding asthma triggers (The Basics)
Patient information: How to use your metered dose inhaler (adults) (The Basics)
Patient information: How to use your dry powder inhaler (adults) (The Basics)
Patient information: Medicines for asthma (The Basics)
Patient information: Asthma and pregnancy (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient information: How to use a peak flow meter (Beyond the Basics)
Patient information: Asthma inhaler techniques in adults (Beyond the Basics)
Patient information: Asthma and pregnancy (Beyond the Basics)
Patient information: Exercise-induced asthma (Beyond the Basics)
Patient information: Asthma symptoms and diagnosis in children (Beyond the Basics)
Patient information: Asthma treatment in children (Beyond the Basics)
Patient information: Asthma inhaler techniques in children (Beyond the Basics)
Patient information: Trigger avoidance in asthma (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Agents affecting the 5-lipoxygenase pathway in the treatment of asthma
Allergen avoidance in the treatment of asthma and allergic rhinitis
An overview of asthma management
Diagnosis of asthma in adolescents and adults
Evaluation of severe asthma in adolescents and adults
Identifying patients at risk for fatal asthma
Natural history of asthma
Severe asthma: Evidence for heterogeneity of the disease
Treatment of acute exacerbations of asthma in adults
Treatment of intermittent and mild persistent asthma in adolescents and adults
Treatment of moderate persistent asthma in adolescents and adults
Treatment of severe asthma in adolescents and adults
The following organizations also provide reliable health information.
-
The National Library of Medicine
(www.nlm.nih.gov/medlineplus/healthtopics.html)
-
National Heart, Lung, and Blood Institute
-
American Lung Association
-
American Academy of Allergy, Asthma, and Immunology
-
American College of Allergy, Asthma, and Immunology
[1-3]
ACKNOWLEDGMENT
The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Suzanne Fletcher, who contributed to an earlier version of this topic review.
Literature review current through: Jul 2013. |This topic last updated: Sep 6, 2012.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use©2013 UpToDate, Inc.
-
Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998; 351:1225. -
National Asthma Education and Prevention Program: Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm (Accessed on September 01, 2007). -
Fanta CH, Haver KH, Cristiano LM. Harvard Medical School guide to taking control of asthma, Free Press (Simon & Schuster), New York 2004.
GRAPHICS
Asthma diary
Use the symptom severity key to give a numerical value to the severity of your asthma. In the notes section, note any triggers that seem to affect your asthma on the day it occurs. Triggers can include colds or infections, exercise, irritants, allergens, and cold air.
Self-assessment form*
* These questions are examples and do not represent a standardized assessment instrument. Other examples of asthma control questions: Asthma Control Questionnaire (Juniper); Asthma Therapy Assessment Questionnaire (Vollmer); Asthma Control Test (Nathan); Asthma Control Score (Boulet).
Reproduced from: National Heart, Blood,and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.
Accessory devices used with metered dose inhalers
These pictures show different types of spacers, with and without a face mask. A spacer makes it easier to use an inhaler and helps more of the medicine reach the lungs. Picture A shows an AeroChamber spacer. Picture B shows an AeroChamber spacer with a face mask. Picture C shows an InspirEase spacer.
Asthma action plan
%: percent.
Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.
School asthma action plan
Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.
School asthma action plan (continued)
Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines for the Diagnosis and Management of Asthma. NIH Publication no. 08-4051, 2007.
School asthma action plan (continued)
Reproduced from: National Heart, Blood, and Lung Institute Expert Panel Report 3 (EPR 3): Guidelines
Patient information: Barrett's esophagus (Beyond the Basics)
AuthorStuart J Spechler, MD |
Section EditorNicholas J Talley, MD, PhD |
Deputy EditorShilpa Grover, MD, MPH |
Contents of this article
-
BARRETT'S ESOPHAGUS OVERVIEW -
BARRETT'S ESOPHAGUS RISK FACTORS -
BARRETT'S ESOPHAGUS SYMPTOMS -
BARRETT'S ESOPHAGUS DIAGNOSIS -
BARRETT'S ESOPHAGUS TREATMENT -
BARRETT'S ESOPHAGUS COMPLICATIONS -
BARRETT'S ESOPHAGUS MONITORING -
PRECANCEROUS CHANGES AND BARRETT'S ESOPHAGUS -
SUMMARY -
WHERE TO GET MORE INFORMATION -
REFERENCES
GRAPHICS
BARRETT'S ESOPHAGUS OVERVIEW
The esophagus is the tube that connects the mouth with the stomach (figure 1). Barrett's esophagus occurs when the normal cells that line the lower part of the esophagus (called squamous cells) are replaced by a different cell type (called intestinal cells). This process usually occurs as a result of repetitive damage to the inside of the esophagus caused by longstanding acid reflux disease, called gastroesophageal reflux disease (GERD). In people with GERD, the esophagus is repeatedly exposed to excessive amounts of stomach acid. Interestingly, the intestinal cells of Barrett's esophagus are more resistant to acid than squamous cells, suggesting that these cells may develop to protect the esophagus from acid exposure. The problem is that the intestinal cells have a risk of transforming into cancer cells.
More detailed information about Barrett's esophagus is available separately. (See "Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus" and "Management of Barrett's esophagus".)
BARRETT'S ESOPHAGUS RISK FACTORS
There are a number of factors that increase the risk of developing Barrett's esophagus:
Age — Barrett's esophagus is most commonly diagnosed in middle-aged and older adults; the average age at diagnosis is approximately 55 years. Children can develop Barrett's esophagus, but rarely before the age of five years.
Gender — Men are more commonly diagnosed with Barrett's esophagus than women.
Ethnic background — Barrett's esophagus is most common in white populations, less common in Hispanic populations, and uncommon in Asian and black populations.
Lifestyle — Smokers are more commonly diagnosed with Barrett's esophagus than nonsmokers.
BARRETT'S ESOPHAGUS SYMPTOMS
Barrett's esophagus itself produces no symptoms. Instead, most people seek help because of symptoms of GERD, including heartburn, regurgitation of stomach contents, and, less commonly, difficulty swallowing.
BARRETT'S ESOPHAGUS DIAGNOSIS
A healthcare provider may suspect Barrett's esophagus based upon a person's symptoms and the risk factors described above. An endoscopy is needed to confirm the abnormal esophageal lining.
Upper endoscopy — Upper endoscopy is a test that allows your doctor to see the inside of the esophagus and stomach. Before the test, you are sedated to prevent discomfort. The doctor will insert a thin lighted tube into the esophagus. The tube has a camera, which allows the doctor to see the lining of the esophagus.
Normally, the lining should appear pale and glossy; in a person with Barrett's esophagus, the lining appears pink or red and velvety. The doctor will remove a small sample of the lining (a biopsy) during the endoscopy so that it can be examined with a microscope for signs of Barrett's. (See "Patient information: Upper endoscopy (Beyond the Basics)".)
Endoscopy detects most (80 percent) but not all cases of Barrett's esophagus. Individual variations in the anatomy of the esophagus and the area where it meets the stomach can make the diagnosis of Barrett's esophagus difficult in some people.
BARRETT'S ESOPHAGUS TREATMENT
The goal of treatment in patients with Barrett's esophagus is to control reflux symptoms. Aggressive reflux treatment may be more effective in preventing cancer than treating only when there are reflux symptoms. (See "Management of Barrett's esophagus".)
Behavior and diet changes — The first priority in treating Barrett's esophagus is to stop the damage to the esophageal lining, which usually means eliminating acid reflux. Most patients are advised to avoid certain foods and behaviors that increase the risk of reflux. Foods that can worsen reflux include:
-
Chocolate -
Coffee and tea -
Peppermint -
Alcohol -
Fatty foods
Acidic juices such as orange or tomato juice may also worsen symptoms. Carbonated beverages can be a problem for some people. (See "Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)".)
Behaviors that can worsen reflux include eating meals just before going to bed, lying down soon after eating meals, and eating very large meals. Placing bricks or blocks under the head of the bed (to raise it by about six inches) help to keep acid in the stomach while sleeping. It is not helpful to use additional pillows under the head.
Medications — A clinician may prescribe medications that reduce the amount of acid produced by the stomach. A class of medications called proton pump inhibitors is commonly recommended. Five different formulations (some of which are available as a generic) are currently available: omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), rabeprazole (Aciphex) and pantoprazole (Protonix); any of these is an acceptable option.
Surgery — People who have severe reflux may benefit from surgical procedures to reduce reflux. Surgery is not the best treatment in all situations, so you should discuss this option with your doctor. More information about surgical treatments for reflux is available in a separate topic review. (See "Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)".)
BARRETT'S ESOPHAGUS COMPLICATIONS
One potential complication of Barrett's esophagus is that, over time, the abnormal esophageal lining can develop early precancerous changes. The early changes may progress to advanced precancerous changes, and finally to frank esophageal cancer. If undetected, this cancer can spread and invade surrounding tissues.
However, progression to cancer is uncommon for any individual patient; studies that follow patients with Barrett's esophagus reveal that fewer than 0.5 percent of patients develop esophageal cancer per year. Furthermore, patients with Barrett's esophagus appear to live approximately as long as people who are free of this condition. Patients often die of other causes before Barrett's esophagus progresses to cancer.
BARRETT'S ESOPHAGUS MONITORING
Monitoring for precancerous changes is recommended for most patients with Barrett's esophagus. At this time, monitoring includes periodic endoscopy with tissue biopsy. (See "Patient information: Upper endoscopy (Beyond the Basics)".)
Although new technologies for monitoring are on the horizon, most are still considered to be experimental. Experts do not agree about the usefulness of monitoring. The benefits of monitoring depend upon each person's chance of developing esophageal cancer, which may be difficult to determine.
Benefits — Reasons to perform endoscopic monitoring include:
-
Monitoring can detect precancerous changes (dysplasia) in the esophageal lining. These changes may indicate that the person has an increased risk of cancer. Early detection may be especially important for younger patients. -
Monitoring may detect cancer at an earlier stage, when it can be more effectively treated.
Limitations — However, not all patients will benefit from endoscopic monitoring.
-
Progression of Barrett's esophagus to cancer is uncommon. -
Endoscopy carries certain risks and often causes anxiety. -
Endoscopy may miss areas with premalignant changes or cancer. -
Even if endoscopy detects cancer, the available treatment options may have unacceptably high risks.
PRECANCEROUS CHANGES AND BARRETT'S ESOPHAGUS
Confirmation and staging — If precancerous changes are discovered, they should be confirmed by a second pathologist, an expert in examining tissue samples. It is sometimes difficult to correctly identify precancerous changes, especially when there is inflammation (usually caused by the ongoing reflux of acid). Many clinicians increase the dose of acid-suppressing medications in this situation.
The precancerous changes must then be graded as "low-grade dysplasia" or "high-grade dysplasia," depending upon their severity.
Treatment options — People with low-grade dysplasia are often told to increase their dose of acid suppressing medication and undergo a repeat endoscopy within 6 to 12 months. The management of low-grade dysplasia is especially controversial. Some physicians recommend frequent endoscopic surveillance for patients with low-grade dysplasia, while others recommend destroying the abnormal tissue with radiofrequency ablation (see below).
A person with high-grade dysplasia has more limited options. The management of this condition is controversial. The optimal treatment depends upon the person's age and health and the patient and physician's preference. The options include removal of the esophagus (esophagectomy) and removing (eg, endoscopic mucosal resection) or destroying (eg, radiofrequency ablation, photodynamic or other ablation therapies) the abnormal tissue using endoscopic techniques.
Esophagectomy — In removing the esophagus, esophagectomy removes all of the precancerous tissue and some of the lymph nodes near the esophagus. However, this treatment has higher rates of procedure-related death and long-term complications than the endoscopic treatments for dysplasia.
Esophagectomy is not necessary in most patients who have dysplasia in Barrett’s esophagus. In some patients, however, it may not be possible to destroy all of the abnormal tissue by endoscopic treatments, and esophagectomy may be recommended for those patients. Esophagectomy should be performed by an experienced physician in a hospital where the procedure is performed frequently. In one study of 340 esophagectomies performed at 25 different hospitals, the mortality rate was 3 percent for patients who had the operation at institutions that did five or more esophagectomies per year, compared to 12 percent for patients treated at institutions where the operation was performed less frequently [1].
Endoscopic treatments — Endoscopic treatments are usually recommended for patients with high-grade dysplasia.
Endoscopic mucosal resection — Endoscopic mucosal resection (EMR) involves the removal of a large but thin area of esophageal tissue through an endoscope. EMR provides large tissue specimens that can be examined by the pathologist to determine the character and extent of the abnormality and determine if an adequate amount of tissue was removed. Therefore, it can help to confirm the person's diagnosis and completely treat the abnormality (if the abnormal tissue is removed completely). However, this technique is generally performed only in specialized centers. Generally, EMR is performed if the endoscopist sees an area of nodularity in the Barrett’s esophagus. EMR is commonly followed by ablation of the remaining Barrett’s esophagus, usually with radiofrequency ablation (see below).
Radiofrequency ablation — Radiofrequency ablation (RFA) is an endoscopic procedure that uses radiofrequency energy (microwaves) to destroy the Barrett’s cells. In short-term studies, RFA has been shown to prevent high-grade dysplasia from progressing to cancer and to prevent low-grade dysplasia from developing more advanced features. However, there is limited information on the long-term outcome of this approach. In up to 5 percent of patients, the procedure causes a complication, such as narrowing of the esophagus, which may require repeated treatments to open the esophagus.
Another concern with RFA is that, in a small minority of patients with high-grade dysplasia (less than 2 percent), there may be cancer in the lymph nodes adjacent to the esophagus. RFA cannot cure cancer in the lymph nodes. In all cases, the patient and family should discuss the risks and benefits of possible treatments with a healthcare provider.
Photodynamic therapy — Photodynamic therapy is a treatment that uses chemical agents, known as photosensitizers, to kill certain types of cells (such as Barrett's cells) when the cells are exposed to laser light. Patients are given the photosensitizer medication into a vein and then undergo endoscopy. During the endoscopy, a laser light is used to activate the photosensitizer and destroy the Barrett's tissue.
However, there is limited information on the long-term outcome of this approach. Furthermore, photodynamic therapy is expensive and available in only a small number of academic medical centers. In up to 40 percent of patients, the procedure causes a complication, such as narrowing of the esophagus, which may require repeated treatments to open the esophagus.
Another concern with photodynamic therapy is that patients with high-grade dysplasia may have areas of invasive cancer that are not treated adequately. Photodynamic therapy has largely been replaced by RFA, which appears to be safer and at least as effective. In all cases, the patient and family should discuss the risks and benefits of possible treatments with a healthcare provider.
SUMMARY
Despite the uncertainties surrounding the monitoring and treatment of Barrett's esophagus, there is consensus on one matter: The available options should be tailored to the individual patient. The following are general guidelines:
-
People with Barrett's esophagus should be treated to decrease reflux symptoms. This may improve or eliminate symptoms of heartburn, reduce inflammation, help prevent complications, and improve the accuracy of endoscopy results. -
People without evidence of precancerous changes (ie, no dysplasia) or esophageal cancer should have endoscopy performed every three to five years to look for the development of precancerous changes, unless there are other medical conditions that increase the small risks usually associated with endoscopy. -
If endoscopy reveals a precancerous change (dysplasia), this finding should be confirmed by at least one expert; if necessary, additional tissue samples should be collected to resolve any doubt. -
People with early precancerous changes (low-grade dysplasia) often are advised to have repeat endoscopy at 6 and 12 months, followed by annual endoscopy if the lesion does not appear to progress. In some cases, RFA may be considered to treat low-grade dysplasia. -
People with advanced precancerous changes (high-grade dysplasia) should have their diagnosis confirmed by an expert. If the diagnosis is confirmed, treatment usually involves a combination of EMR and RFA.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient information: Acid reflux (gastroesophageal reflux disease) in adults (The Basics)
Patient information: Barrett's esophagus (The Basics)
Patient information: Esophageal cancer (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient information: Upper endoscopy (Beyond the Basics)
Patient information: Acid reflux (gastroesophageal reflux disease) in adults (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Autofluorescence endoscopy for Barrett's esophagus
Endoscopic resection for treatment of high-grade dysplasia and early cancer in Barrett's esophagus
Epidemiology, clinical manifestations, and diagnosis of Barrett's esophagus
Management of Barrett's esophagus
Narrow band imaging in Barrett's esophagus
Pathogenesis of Barrett's esophagus and its malignant transformation
Photodynamic therapy for ablation of Barrett's esophagus
Radiofrequency ablation for Barrett's esophagus
The following organizations also provide reliable health information.
-
National Library of Medicine
(www.nlm.nih.gov/medlineplus/healthtopics.html)
-
The American Gastroenterological Society
-
The American College of Gastroenterology
-
The American Society for Gastrointestinal Endoscopy
[1-9]
Literature review current through: Jul 2013. |This topic last updated: Jul 18, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use©2013 UpToDate, Inc.
-
Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000; 119:1126. -
Sharma P, McQuaid K, Dent J, et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004; 127:310. -
Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation. Am J Med 2001; 111:33. -
Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol 2003; 98:1931. -
Shaheen NJ, Inadomi JM, Overholt BF, Sharma P. What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut 2004; 53:1736. -
Hirota WK, Zuckerman MJ, Adler DG, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006; 63:570. -
Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103:788. -
American Gastroenterological Association, Spechler SJ, Sharma P, et al. American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology 2011; 140:1084. -
Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140:e18.
GRAPHICS
Gastroesophageal reflux disease (GERD)
When we eat, food is carried from the mouth through the esophagus, a tube-like structure that is approximately 10 inches long and 1 inch wide in adults. At the lower end of the esophagus, where it joins the stomach, there is a circular ring of muscle that relaxes and opens when food reaches that point, called the lower esophageal sphincter (LES). This allows food to enter the stomach and then closes to prevent the back-up of food and acid into the esophagus. Reflux can occur if the LES is weak or stays relaxed too long.
Patient information: Acute bronchitis in adults (Beyond the Basics)
Contents of this article
- BRONCHITIS OVERVIEW
- BRONCHITIS CAUSES
- BRONCHITIS SYMPTOMS
- BRONCHITIS DIAGNOSIS
- BRONCHITIS TREATMENT
- PREVENTING THE SPREAD OF ILLNESS
- WHERE TO GET MORE INFORMATION
- REFERENCES
GRAPHICS
Bronchitis develops when there is swelling and irritation of the bronchi, the large tubes that carry air to the lungs (figure 1). There are two types of bronchitis: acute (sudden onset) and chronic (long-standing).
Acute bronchitis often occurs with a viral infection, such as the common cold, and is sometimes called a "chest cold”. The most common symptom of acute bronchitis is a nagging cough. Treatment of acute bronchitis usually involves treating the symptoms, such as sore throat and congestion. Antibiotics do not help to eliminate acute bronchitis caused by a virus. Antiviral agents are useful in some cases of acute bronchitis due to influenza, but there are no antiviral agents for other forms of viral bronchitis.
This article will review the causes, symptoms, diagnosis, and treatment of acute bronchitis. Articles that discuss the common cold and sore throat are also available. (See "Patient information: The common cold in adults (Beyond the Basics)" and "Patient information: Sore throat in adults (Beyond the Basics)".)
Chronic bronchitis is discussed separately. (See "Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)".) More detailed information about acute bronchitis is available by subscription. (See "Acute bronchitis in adults".)
BRONCHITIS CAUSES
Most cases of bronchitis are caused by a viral infection of the upper airways, such as the common cold or the flu. Less commonly, a bacterium called Bordetella pertussis, which causes pertussis (whooping cough), is the cause. (See 'Whooping cough' below.)
BRONCHITIS SYMPTOMS
The most common symptoms of acute bronchitis include:
- A persistent cough; this may last 10 to 20 days
- Some people cough up mucus, which may be clear, yellow, or green in color
Fever is not common in people with acute bronchitis. However, having a fever can be a sign of another condition, such as the flu or pneumonia. (See "Patient information: Influenza symptoms and treatment (Beyond the Basics)" and "Patient information: Pneumonia in adults (Beyond the Basics)".)
Conditions with similar features — There are other conditions that have symptoms similar to those of acute bronchitis.
- Chronic cough — A persistent cough that lasts more than eight weeks is considered a chronic cough, which is discussed in detail elsewhere. (See "Patient information: Chronic cough in adults (Beyond the Basics)".)
- Chronic bronchitis — Chronic bronchitis is defined as a cough that occurs on most days of the month for at least three months of the year during two consecutive years. This condition is discussed separately. (See "Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)".)
- Pneumonia — Signs of pneumonia include fever and a fast heart and breathing rate. (See "Patient information: Pneumonia in adults (Beyond the Basics)".)
- Postnasal drip — Postnasal drip occurs when secretions drain from the sinuses into the throat. This can cause the throat to feel irritated, which causes you to feel like you need to clear your throat frequently. Postnasal drip can be caused by the common cold, allergies, sinusitis, or environmental irritants. (See "Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)".)
Most people who have a persistent cough after an upper respiratory infection (cold) do not need to see a healthcare provider. Diagnostic testing, such as x-rays, cultures, and blood tests, are not usually needed for people with acute bronchitis. However, testing may be recommended if your diagnosis is not clear based upon your examination or if another condition, such as pneumonia, is suspected.
When to seek help — You should call your healthcare provider if you have any of the following:
- Fever (temperature greater than 100.4º F or 38º C)
- A cough that lasts longer than 10 days
- Chest pain with coughing, difficulty breathing, or coughing up blood
- A barking cough that makes it hard to speak, especially if it persists
- Cough accompanied by unexplained weight loss
People who are older than 75 do not always have a fever or other concerning symptoms. If you are over 75 years and you have a persistent cough, you should call your clinician to determine if and when an office visit is recommended.
BRONCHITIS TREATMENT
Relief of symptoms — There is no specific treatment for bronchitis. There are a few treatments available for the common cold. (See "Patient information: The common cold in adults (Beyond the Basics)".)
- A nonsteroidal antiinflammatory drug (ibuprofen, naproxen), aspirin, or acetaminophen (Tylenol®) can help to relieve the pain of a sore throat or headache.
- Heated, humidified, air can improve symptoms of nasal congestion and runny nose, and has few to no side effects.
- Cough suppressant medications have not been shown to be helpful for most patients.
- Inhaler medications, commonly used for patients with asthma, are only helpful for those patients whose symptoms include wheezing or airflow obstruction and would require prescription.
Antibiotics — Antibiotics are NOT helpful for most people with bronchitis since the illness is typically caused by a virus. Antibiotics treat bacterial, not viral infections.
Many people request antibiotics in the hopes that it will get rid of the cough, and some people even think that antibiotics have helped on previous occasions. However, there is no benefit of antibiotics for most cases of bronchitis.
Whooping cough — Whooping cough is caused by a bacterium, Bordetella pertussis. A vaccine is routinely given during childhood, and again during adolescence or adulthood, to reduce the risk of becoming infected with pertussis. However, the illness can still develop in those who were vaccinated. (See "Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults".)
Signs of whooping cough in adults include repeated "spasms" of severe coughing, sometimes followed by vomiting. Whooping cough often occurs as outbreaks, usually involving people who are incompletely immunized. If whooping cough is suspected, your healthcare provider may prescribe an antibiotic. Antibiotics will not help the cough, but can reduce the risk of spreading the infection to others. (See "Treatment and prevention of Bordetella pertussis infection in adolescents and adults".)
PREVENTING THE SPREAD OF ILLNESS
Hand washing is an essential and highly effective way to prevent the spread of infection. Wet your hands with water and plain soap and rub them together for 15 to 30 seconds. Pay special attention to the fingernails, between the fingers, and the wrists. Rinse your hands thoroughly, and dry with a single use towel.
Alcohol-based hand rubs are a good alternative for disinfecting hands if a sink is not available. Spread the hand rub over the entire surface of your hands, fingers, and wrists until dry. You can use hand rubs repeatedly without irritating the skin or losing effectiveness. Hand rubs are available as a liquid or wipe in small, portable sizes that are easy to carry in a pocket or handbag. When a sink is available, you should wash visibly soiled hands with soap and water.
Wash your hands before preparing food and eating; after going to the bathroom; and after coughing, blowing the nose, or sneezing. While it is not always possible to limit contact with people who are ill, avoid touching your eyes, nose, or mouth after direct contact, when possible.
In addition, use a tissue to cover your mouth when sneezing or coughing. Throw away used tissues promptly and then wash your hands. Sneezing/coughing into the sleeve of your clothing (at the inner elbow) is another way of containing sprays of saliva and secretions and does not contaminate your hands. Sneezing and coughing without covering your mouth can spread infection to anyone within six feet.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient information: Acute bronchitis (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient information: The common cold in adults (Beyond the Basics)
Patient information: Sore throat in adults (Beyond the Basics)
Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)
Patient information: Influenza symptoms and treatment (Beyond the Basics)
Patient information: Pneumonia in adults (Beyond the Basics)
Patient information: Chronic cough in adults (Beyond the Basics)
Patient information: Allergic rhinitis (seasonal allergies) (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Acute bronchitis in adults
Clinical manifestations and diagnosis of Bordetella pertussis infections in adolescents and adults
Management of infection in acute exacerbations of chronic obstructive pulmonary disease
Etiology and evaluation of hemoptysis in adults
Fluoroquinolones
Respiratory syncytial virus infection: Clinical features and diagnosis
The common cold in adults: Treatment and prevention
Treatment and prevention of Bordetella pertussis infection in adolescents and adults
The following organizations also provide reliable health information.
- National Library of Medicine
(www.nlm.nih.gov/medlineplus/bronchitis.html) - Centers for Disease Control and Prevention (CDC)
(www.cdc.gov/getsmart/antibiotic-use/URI/bronchitis.html)
[1-3]
- Snow V, Mottur-Pilson C, Gonzales R, et al. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134:518.
- Wenzel RP, Fowler AA 3rd. Clinical practice. Acute bronchitis. N Engl J Med 2006; 355:2125.
- Braman SS. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006; 129:95S.